E-LIB Suche - Ergebnisse für: SZEKANECZ, ÉVA

1

Rheumatoid arthritis disease activity and adverse events in..:

Karpouzas, George A. ; Szekanecz, Zoltán ; Baecklund, Eva...
Therapeutic Advances in Musculoskeletal Disease. 15 (2023) - p. , 2023

Link: https://doi.org/10.1177/..

2

Effectiveness and waning of protection with the BNT162b2 va..:

Szekanecz, Zoltán ; Vokó, Zoltán ; Surján, Orsolya...
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

3

Evaluation of the Efficacy of BBIBP-CorV Inactivated Vaccin..:

Rákóczi, Éva ; Magócs, Gusztáv ; Kovács, Sára...
Diagnostics. 13 (2023) 3 - p. 556 , 2023

Link: https://doi.org/10.3390/..

4

Immune-related adverse events of anti-PD-1 immune checkpoin..:

Sebestyén, Enikő ; Major, Nóra ; Bodoki, Levente...
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

5

Table_2_Effectiveness and waning of protection with the BNT..:

Zoltán Szekanecz ; Zoltán Vokó ; Orsolya Surján...
doi:10.3389/fimmu.2023.1247129.s002. , 2023

Link: https://doi.org/10.3389/..

6

Rheumatoid arthritis disease activity and adverse events in..:

Karpouzas, George A ; Szekanecz, Zoltan ; Baecklund, Eva...
Therapeutic Advances in Musculoskeletal Disease, 1759-7218, 2023, 15,. , 2023

Link: http://urn.kb.se/resolve..

7

Evaluation of the Efficacy of BBIBP-CorV Inactivated Vaccin..:

Rákóczi, Éva ; Magócs, Gusztáv ; Kovács, Sára...
Diagnostics. -13 : 3 (2023), p. 1-12. -Diagnostics. - 2075-4418. - 2075-4418. , 2023

Link: https://hdl.handle.net/2..

8

Table_2_Effectiveness and waning of protection with the BNT..:

Zoltán Szekanecz ; Zoltán Vokó ; Orsolya Surján...
doi:10.3389/fimmu.2023.1247129.s002. , 2023

Link: https://doi.org/10.3389/..

9

Evaluation of the Efficacy of BBIBP-CorV Inactivated Vaccin..:

Éva Rákóczi ; Gusztáv Magócs ; Sára Kovács...
https://www.mdpi.com/2075-4418/13/3/556. , 2023

Link: https://doi.org/10.3390/..

10

Table_5_Effectiveness and waning of protection with the BNT..:

Zoltán Szekanecz ; Zoltán Vokó ; Orsolya Surján...
doi:10.3389/fimmu.2023.1247129.s005. , 2023

Link: https://doi.org/10.3389/..

11

Table_1_Effectiveness and waning of protection with the BNT..:

Zoltán Szekanecz ; Zoltán Vokó ; Orsolya Surján...
doi:10.3389/fimmu.2023.1247129.s001. , 2023

Link: https://doi.org/10.3389/..

12

Table_4_Effectiveness and waning of protection with the BNT..:

Zoltán Szekanecz ; Zoltán Vokó ; Orsolya Surján...
doi:10.3389/fimmu.2023.1247129.s004. , 2023

Link: https://doi.org/10.3389/..

13

Immune-related adverse events of anti-PD-1 immune checkpoin..:

Sebestyén, Enikő ; Major, Nóra ; Bodoki, Levente...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618004/. , 2023

Link: http://www.ncbi.nlm.nih...

14

Rheumatoid arthritis disease activity and adverse events in..:

Karpouzas, George A ; Szekanecz, Zoltán ; Baecklund, Eva...
Therapeutic Advances in Musculoskeletal Disease. -15 (2023), p. 1-14. -Ther. Adv. Musculoskelet. Dis. - 1759-720X. - 1759-7218. , 2023

Link: https://hdl.handle.net/2..

15

Effectiveness and waning of protection with the BNT162b2 va..:

Szekanecz, Zoltán ; Vokó, Zoltán ; Surján, Orsolya...
Frontiers in Immunology. -14 (2023), p. 1-8. -Front. Immunol. - 1664-3224. , 2023

Link: https://hdl.handle.net/2..